ZE 50-0134 Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Pipeline

Phase 1: 2

Top Sponsors

Lomond Therapeutics Holdings, Inc.2

Indications

Cancer2
Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia1
SLL (Small Lymphocytic Lymphoma)1
CLL (Chronic Lymphocytic Leukemia)1
CLL / SLL1

Other1 trial

A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients

Phase 1

Louisville, Kentucky1 trial

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

Norton Cancer Institute, St. Matthews Campus

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.